Search News & Insights
Matheson ranked amongst top European law firms for M&A deals
Matheson has ranked amongst the top European law firms in 2014 for Mergers and Acquisitions (M&A) transactions. Research by both Thomson Reuters and Mergermarket confirms that Matheson is within the top tier of European law firms in terms of M&A deals by value.
During 2014, Matheson advised on the largest European deal of the year, Medtronic’s $42.9 billion acquisition of Covidien, as well as the third largest global transaction of the year, the $66 billion merger agreement under which Actavis will acquire Allergan in a $66 billion cash and stock transaction. We also advised Auxilium Pharmaceuticals Inc. on its $2.6 billion merger with Endo International plc and Questcor Pharmaceuticals on its $5.6 billion merger with Mallinckrodt.
This continues Matheson’s established track record of advising on high profile international M&A transactions.